Regeneron Pharmaceuticals, Inc. (REGN): Depreciation & Amortization
$543.70M
Year ended 2025-12-31
$528.60M
Trailing 12 months to 2026-06-30
+16.8%
3-year compound annual growth
+18.2%
5-year compound annual growth
+21.9%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $543.70M | +12.6% | 2026-02-04, From 2025-01-01 |
| 2024-12-31 | $482.90M | +14.7% | 2026-02-04, From 2024-01-01 |
| 2023-12-31 | $421.00M | +23.3% | 2026-02-04, From 2023-01-01 |
| 2022-12-31 | $341.40M | +19.3% | 2025-02-05, From 2022-01-01 |
| 2021-12-31 | $286.20M | +21.3% | 2024-02-05, From 2021-01-01 |
| 2020-12-31 | $235.90M | +12.2% | 2023-02-06, From 2020-01-01 |
| 2019-12-31 | $210.30M | +41.9% | 2022-02-07, From 2019-01-01 |
| 2018-12-31 | $148.20M | +1.9% | 2021-02-08, From 2018-01-01 |
| 2017-12-31 | $145.50M | +39.0% | 2020-02-07, From 2017-01-01 |
| 2016-12-31 | $104.70M | +39.8% | 2019-02-07, From 2016-01-01 |
| 2015-12-31 | $74.91M | +42.2% | 2018-02-08, From 2015-01-01 |
| 2014-12-31 | $52.69M | +27.9% | 2017-02-09, From 2014-01-01 |
| 2013-12-31 | $41.20M | +11.5% | 2016-02-11, From 2013-01-01 |
| 2012-12-31 | $36.94M | +18.8% | 2015-02-12, From 2012-01-01 |
| 2011-12-31 | $31.08M | +57.9% | 2014-02-13, From 2011-01-01 |
| 2010-12-31 | $19.69M | +38.6% | 2013-02-15, From 2010-01-01 |
| 2009-12-31 | $14.20M | +25.8% | 2012-02-21, From 2009-01-01 |
| 2008-12-31 | $11.29M | n/a | 2011-02-17, From 2008-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $543.70M | +12.6% |
| Viatris Inc (VTRS) | 2025-12-31 | $2.80B | -3.3% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $209.80M | +1.3% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.00B | -5.4% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.21B | -4.7% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $487.00M | -2.0% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $141.69M | -17.5% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $680.00M | +2.7% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $4.01B | -58.2% |
Compare REGN, VTRS, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗